NEUROENDOCRINE TUMORS OF THE CERVIX

Keywords

CD56 / neuroendocrine tumor / carcinoid / chromogranin A / neuron-specific enolase / CD56 / synaptophysin

References

[1] Ceplin M., Kvols L. (eds.) Neuroendocrine tumors: a guide for physicians (translation from English), Moscow., Practical medicine. 2011: 11; 17—19; 23; 37; 43; 54; 88; 100 (in Russian). (Кэплин М., Кволс Л. (ред.) Нейроэндокринные опухоли: руководство для врачей: [пер. с англ.] Москва: Практическая медицина. 2011: 11; 17—19; 23; 37; 43; 54; 88; 100.)

[2] Modlin I.M., Lye K.D., Kidd M. A 5-decade analysis of 13, 715 carcinoid tumors. Cancer. 2003; 97(4): 934-59.

[3] Surveillance, Epidemiology, and End Results (SEER), Program 2005 Public-use Data (1973-2002). National Cancer Institute, DC-CPS, Surveillance Research Program, Cancer Statistics Branch. National Cancer Institute, Bethesda, MD. (Released April 2005, based on the November 2004 submission.)

[4] Simonenko V.B., Dulin P.A., Makanin M.A. Neuroendocrine tumors. Moscow. 2010: 6, 16 (in Ryssian). (Симоненко В.Б., Дулин П.А., Маканин М.А. Нейроэндокринные опухоли. Москва. 2010: 6; 16.)

[5] Viswanathan A.N., Deavers M.T., Jhingran A., Ramirez P.T., Levenback C., Eifel P.J. Small cell neuroendocrine carcinoma of the cervix: outcome and patterns of recurrence. Gynecol. Oncol. 2004; 93: 27-33.

[6] Crowder S., Tuller. Small cell carcinoma of the female genital tract. Semin. Oncol. 2007; 34: 57—63.

[7] Lee J.M., Lee K.B., Nam J.H. et al. Prognostic factors in FIGO stage IB-IIA small cell neuroendocrine carcinoma of the uterine cervix treated surgically: Results of a multi-center retrospective Korean study. Ann Oncol. 2008; 19: 321-6.

[8] Tsunoda S., Jobo T., Arai M. et al. Small-cell carcinoma of the uterine cervix: A clincopathologic study of 11 cases. Int. J. Gynecol. Cancer. 2005; 15:295-300.

[9] Boruta D.M., Schorge J.O., Duska L.A. et al. Multimodality therapy in early-stage neuroendocrine carcinoma of the uterine cervix. Gynecol. Oncol. 2001; 81: 82—7.

[10] Lee S.W., Nam J.H., Kim D.Y., Kim J.H., Kim K.R., Kim Y.M., Kim Y.T. Unfavorable prognosis of small cell neuroendocrine carcinoma of the uterine cervix: a retrospective matched case-control study. Int. J. Gynecol. Cancer. 2010; 20: 411-6.

[11] Chen J., MacDonald O.K., Gaffney D.K. Incidence, mortality, and prognostic factors of small cell carcinoma of the cervix. Obstet Gynecol. 2008; 111: 1394-14.

[12] Ruoslahti E. Integrins. J. Clin. Invest. 1991; 87: 1—5.

[13] Albelda S.M. Role of integrins and other cell adhesion molecules in tumor progression and metastasis. Lab. Invest. 1993; 68: 4—17.

[14] Kumar C.C. Signaling by integrin receptors. Oncogene. 1998; 17: 1365—73.

[15] Clezardin P. Recent insights into the role of integrins in cancer metastasis. Cell. Mol. Life Sci. 1998; 54: 541—8.

[16] Sanders R.J., Mainiem F., Giancotti F.P. The role of integrins in tumorogenesis and metastasis. Cancer Invest. 1998; 16: 329—44.

[17] Reig Castillejo A., Membrive Conejo I., Foro Arnalot P., Rodríguez de Dios N., Algara López M. Neuroendocrine small cell carcinoma of the uterine cervix. Clin Transl Oncol. 2010 Jul; 12 (7): 512—3.

[18] Bermudez A., Vighi S., Garcia A., Sardi J. Neuroendocrine cervical carcinoma: a diagnostic and therapeutic challenge. Gynecol. Oncol. 2001; 82: 2—9.

[19] Chan J.K., Loizzi V., Burger R.A., Rutgers J., Monk B.J. Prognostic factors in neuroendocrine small cell cervical carcinoma: A multivariate analysis. Cancer. 2003; 97: 568-74.

[20] Cohen J.G., Chan J.K., Kapp D.S. The management of small-cell carcinomas of the gynecologic tract. Curr Opin Oncol. 2012 Sep; 24(5): 572—9. doi: 10.1097/CCO.0b013e3283565ed6.

[21] Zivanovica O., Leitao M.M., Parkb K.J., Zhaob H., Diaza J.P., Konnerd J., Alektiarc K., Chia D.S., Abu-Rustuma N.R., Aghajaniand C. Small cell neuroendocrine carcinoma of the cervix: Analysis of outcome, recurrence pattern and the impact of platinum-based combination chemotherapy, Gynecologic Oncology. Volume 112, Issue 3, March 2009; 590-3.

[22] Rossi A., Maione P., Palazzolo G., Sacco P.C., Ferrara M.L., Falanga M., Gridelli C. Review New targeted therapies and smallcell lung cancer. Clin Lung Cancer. 2008 Sep; 9 (5): 271—9.

[23] Tian W.J., Zhang M.Q., Shui R.H. Prognostic factors and treatment comparison in early-stage small cell carcinoma of the uterine cervix. Oncol Lett. 2012 January; 3 (1): 125-130. Published online 2011 October 12. doi: 10.3892/ol.2011.439

[24] Kim Y.B., Barbuto D., Lagasse L.D., Karlan B.Y. Successful treatment of neuroendocrine small cell carcinoma of the cervix metastatic to regional lymph nodes. Gynecol Oncol. 1996 Sep; 62 (3): 411—4.

RIGHTS & PERMISSIONS

Eco-Vector